POR Gene: Cytochrome P450 Oxidoreductase
A master regulator of cytochrome P450 enzyme activity, essential for drug metabolism, steroidogenesis, and cholesterol biosynthesis.
Gene Information Card
| Symbol | POR |
|---|---|
| Full Name | Cytochrome P450 Oxidoreductase |
| Gene Type | Protein coding |
| Chromosomal Location | 7q11.23 |
| NCBI Gene ID | 5447 ncbi.nlm.nih.gov/gene/5447 |
| Ensembl ID | ENSG00000127948 |
| UniProt ID | P16435 |
| OMIM ID | 124015 |
| HGNC ID | 9208 |
| Aliases | CPR, CYPOR, P450R |
Description
The POR gene encodes the enzyme cytochrome P450 oxidoreductase (POR), a crucial membrane-bound flavoprotein that serves as the universal electron donor for all microsomal cytochrome P450 (CYP) enzymes. These CYP enzymes are involved in the metabolism of a vast array of endogenous and exogenous compounds, including drugs, steroids, fatty acids, and xenobiotics. POR transfers electrons from NADPH to CYP enzymes, enabling their catalytic activity. This process is essential for various physiological functions, including steroid hormone synthesis, cholesterol biosynthesis, drug detoxification, and the metabolism of retinoic acid. Mutations in the POR gene can lead to a spectrum of disorders, most notably Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis | Loss-of-function mutations in POR reduce the electron transfer to CYP21A2 and CYP17A1, impairing adrenal and gonadal steroidogenesis. This leads to ambiguous genitalia and skeletal malformations. | OMIM #201750; ClinVar; Multiple publications (e.g., Flück et al., 2004) |
| Disordered steroidogenesis (isolated) | Specific POR mutations can cause a milder phenotype with only steroid hormone imbalances, affecting sex development and puberty, without the severe skeletal features of Antley-Bixler syndrome. | OMIM #613571; ClinVar; Literature reports |
| Altered drug metabolism | POR variants can modify the activity of hepatic CYP enzymes, leading to significant inter-individual variability in the metabolism and efficacy of many clinically used drugs, including statins, warfarin, and certain anticancer agents. | ClinVar; Pharmacogenomic studies (e.g., Gomes et al., 2009) |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 32.4 | High |
| Adrenal Gland | 25.1 | High |
| Small Intestine | 18.7 | Medium |
| Kidney | 12.3 | Medium |
| Lung | 8.5 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 (Liver) | 45.2 | High expression; used for drug metabolism studies. |
| A549 (Lung) | 12.8 | Moderate expression. |
| MCF7 (Breast) | 9.1 | Low to moderate expression. |
| K562 (Leukemia) | 5.4 | Low expression. |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| A287P | Missense | Common in Caucasian populations (~10-20% allele frequency) | Reduced enzyme activity; associated with Antley-Bixler syndrome and disordered steroidogenesis. |
| R457H | Missense | Rare | Severe loss of function; causes classic Antley-Bixler syndrome. |
| Y181D | Missense | Rare | Loss of function; associated with disordered steroidogenesis. |
| C569Y | Missense | Rare | Loss of function; linked to Antley-Bixler syndrome. |
Mutation functional classification
Loss of Function (LOF)
The majority of disease-associated POR mutations are loss-of-function. They reduce or abolish the enzyme's ability to transfer electrons to CYP enzymes, leading to impaired steroidogenesis and drug metabolism.
Gain of Function (GOF)
No clear gain-of-function mutations have been clinically characterized for POR. Some variants may alter substrate specificity, but this is not a dominant mechanism.
Dominant Negative (DN)
POR functions as a single polypeptide. A mutant allele could potentially exert a dominant-negative effect by competing with the wild-type protein for binding to CYP enzymes or by forming non-functional dimers, but this is not a well-established mechanism for POR-related diseases.
View complete mutation data:
Gene Ontology (GO)
| • NADPH binding | • NADPH-hemoprotein reductase activity |
| • oxidoreductase activity | • flavin adenine dinucleotide binding |
| • flavin mononucleotide binding | • protein binding |
| • integral component of membrane | • endoplasmic reticulum membrane |
| • xenobiotic metabolic process | • steroid metabolic process |
| • cholesterol biosynthetic process | • drug metabolic process |
Pathways
• Steroid hormone biosynthesis
• Cholesterol metabolism
• Drug metabolism - cytochrome P450
• Retinoic acid metabolism
• Xenobiotics metabolism
Protein Summary
The POR protein is a 82 kDa endoplasmic reticulum membrane-bound flavoprotein. It contains two flavin cofactors, FAD and FMN, which are essential for its electron transfer function. The protein is composed of several domains: an N-terminal membrane-binding domain, a FMN-binding domain, a connecting domain, and a C-terminal FAD/NADPH-binding domain. POR accepts electrons from NADPH via FAD and transfers them one at a time to the heme iron of various microsomal CYP enzymes. This electron transfer is the rate-limiting step in many CYP-catalyzed reactions. The crystal structure of rat POR has been solved, revealing a hinge-like motion that allows the FMN domain to interact with different CYP partners.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NADC30M、NADCGP5、PorB Overexpression CHO-K1 Stable Cell Line | EDC90045 | Hamster | Details Get a Quote | |
| EPOR Knockout HEK293 Cell Line | EDJ-KQ461 | Human | 2057 | Details Get a Quote |
| ADIPOR1 Knockout HEK293 Cell Line | EDJ-KQ1860 | Human | 51094 | Details Get a Quote |
| ADIPOR2 Knockout HEK293 Cell Line | EDJ-KQ1861 | Human | 79602 | Details Get a Quote |
| RIPOR1 Knockout HEK293 Cell Line | EDJ-KQ2632 | Human | 79567 | Details Get a Quote |
| POR Knockout HEK293 Cell Line | EDJ-KQ3088 | Human | 5447 | Details Get a Quote |
| RIPOR2 Knockout HEK293 Cell Line | EDJ-KQ6070 | Human | 9750 | Details Get a Quote |
| TOPORS Knockout HEK293 Cell Line | EDJ-KQ6950 | Human | 10210 | Details Get a Quote |
| ELAPOR2 Knockout HEK293 Cell Line | EDJ-KQ8235 | Human | 222223 | Details Get a Quote |
| RIPOR3 Knockout HEK293 Cell Line | EDJ-KQ9824 | Human | 140876 | Details Get a Quote |
| ELAPOR1 Knockout HEK293 Cell Line | EDJ-KQ13273 | Human | 57535 | Details Get a Quote |
| PORCN Knockout HEK293 Cell Line | EDJ-KQ14835 | Human | 64840 | Details Get a Quote |
| RIPOR1 Knockout HeLa Cell Line | EDJ-KQ22017 | Human | 79567 | Details Get a Quote |
| EPOR Knockout A-549 Cell Line | EDJ-KQ18769 | Human | 2057 | Details Get a Quote |
| EPOR Knockout HCT 116 Cell Line | EDJ-KQ18770 | Human | 2057 | Details Get a Quote |
Displaying Records 1 To 15 Of 47 Records
- 1
- 2
- Next Page »